
Columbus Ledger-Enquirer (12.18.02) - Wednesday, December 18, 2002
Mark Rice
Only those students and staff in the boy's classes and on the bus he rides to school were screened. Testing only about 10 percent of the school's population is adequate because those persons tested were the ones who had closest contact with the boy. "TB isn't like measles, where anybody that passes you in the hallway could get infected," said Dr. Zsolt Koppanyi, director of the West Central Georgia Health District. "It's most likely to be transmitted in a confined space." He said officials are still trying to track down all the people who had close contact with the boy.
Koppanyi said he called school Principal Susan Bryant immediately after a local hospital official contacted his department Monday to report the TB case. The boy has been discharged and is taking medicine at home. "We can't tell what stage of the disease he is in yet," Koppanyi said, adding that improperly treated TB can be deadly.
This is the 32nd TB case this year in the district's 16- county region, said department TB Coordinator Rosia Thomas. It is rare for more than 100 students to be screened at once. Brenda Dozier, assistant superintendent for student services, said she could not recall a similar case in her 32 years in the district.
Bryant sent a letter home with selected students to ask their parents for permission to be tested. She was not aware of any family that refused. Four Health Department nurses joined two school nurses to administer the TB tests at the school.
021218
AD022449
Copyright © 2002 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.